what does semaglutide look like GLP-1s Semaglutide Weight Loss Treatment: GLP-1

Tirzepatide: 20.2% in SURMOUNT-5 In the head-to-head SURMOUNT-5 trial, tirzepatide reached 20.2% average weight loss compared with 13.7% for semaglutide at 72 weeks

00:15:24 Vickie Danaher So when you put all that together, the goal isnt to say that one medication is universally better, but to help match the option to each patients preferences, routine, risk factors, and values

The addition of GIPR activity was the key pharmacological innovation of tirzepatide, enabling greater weight loss than pure GLP-1 agonism

Medications The amount of vitamin B12 in your body may decrease as a result of taking some medications

#Pharmacology #Gastroenterology #Medicine #ClinicalPharmacology #PPIs #GERD #PepticUlcer #MedicalEducation #Healthcare #DrugMechanism #EvidenceBasedMedicine To view or add a comment, sign in Here it is our major consensus statements regarding fatty liver (#MASLD), published previously

,